CINECA IRIS Institutional Research Information System

FORNARO, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.876
AS - Asia 968
EU - Europa 548
SA - Sud America 191
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 52
Totale 3.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.817
SG - Singapore 352
CN - Cina 222
IT - Italia 158
BR - Brasile 151
HK - Hong Kong 133
VN - Vietnam 117
SE - Svezia 95
DE - Germania 73
GB - Regno Unito 54
CI - Costa d'Avorio 50
FR - Francia 35
CA - Canada 30
IN - India 28
FI - Finlandia 24
RU - Federazione Russa 20
TR - Turchia 20
BD - Bangladesh 19
AT - Austria 18
NL - Olanda 18
SN - Senegal 18
AR - Argentina 15
IQ - Iraq 12
ES - Italia 10
MX - Messico 10
JP - Giappone 9
EC - Ecuador 8
LT - Lituania 8
PL - Polonia 8
ID - Indonesia 7
PK - Pakistan 7
UZ - Uzbekistan 7
KR - Corea 6
NG - Nigeria 6
VE - Venezuela 6
BG - Bulgaria 5
KE - Kenya 5
UA - Ucraina 5
ZA - Sudafrica 5
AL - Albania 4
CL - Cile 4
CR - Costa Rica 4
PH - Filippine 4
CO - Colombia 3
CZ - Repubblica Ceca 3
HN - Honduras 3
MY - Malesia 3
PA - Panama 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
EE - Estonia 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BZ - Belize 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MM - Myanmar 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.676
Salva come PNG Salva come JPEG
Città #
Ashburn 222
Singapore 191
San Jose 172
Hong Kong 129
Santa Clara 129
Chandler 86
Shanghai 59
Dallas 52
Abidjan 50
New York 49
Council Bluffs 47
Los Angeles 45
Munich 38
Florence 33
Ho Chi Minh City 31
Boardman 30
Hanoi 25
London 25
Beijing 24
Milan 23
Colorado Springs 18
Dakar 18
Buffalo 15
Fairfield 15
Lauterbourg 15
Lawrence 15
Princeton 15
Vienna 15
Istanbul 14
Redondo Beach 12
Wilmington 12
Helsinki 11
Medford 11
Turku 11
Chennai 10
Frankfurt am Main 10
Houston 10
Montreal 10
São Paulo 10
Da Nang 9
San Diego 9
Atlanta 8
Baltimore 8
Denver 8
Kent 8
Memphis 8
Pisa 8
Tokyo 8
Baghdad 7
Bremen 7
Haiphong 7
Mexico City 7
Nuremberg 7
Ogden 7
Phoenix 7
Toronto 7
Warsaw 7
Düsseldorf 6
Orem 6
Poplar 6
Quanzhou 6
Amsterdam 5
Brooklyn 5
Cascina 5
Chicago 5
Curitiba 5
Fuzhou 5
Lagos 5
Sofia 5
Tashkent 5
Turin 5
Biên Hòa 4
Boston 4
Bắc Ninh 4
Miami 4
Portsmouth 4
Seacroft 4
Thái Nguyên 4
Tirana 4
Ankara 3
Bexley 3
Elk Grove Village 3
Hyderabad 3
Hải Dương 3
Manchester 3
Olomouc 3
Panama City 3
Philadelphia 3
Redmond 3
Rome 3
San Francisco 3
San José 3
Seo-gu 3
Stockholm 3
Vicopisano 3
Vilnius 3
Woodbridge 3
Amman 2
Bacoli 2
Belo Horizonte 2
Totale 2.010
Salva come PNG Salva come JPEG
Nome #
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 296
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index 154
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 154
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 143
Association of NOS3 and ANGPT2 gene polymorphisms with survival in patients with hepatocellular carcinoma receiving sorafenib: Results of the multicenter prospective INNOVATE study 140
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 129
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 123
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 123
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 119
Cholangiocarcinoma: new perspectives for new horizons 118
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 117
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients 116
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 116
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 115
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 114
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: Clinics and pathology are not enough 114
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 113
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors 111
Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study 104
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 103
Combination chemotherapy in patients with advanced pancreatic cancer with an eastern cooperative oncology group performance status of 2: Lights and shadows of a frail route 102
FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer 98
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 86
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 86
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action 83
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 81
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 80
Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Carcinomatosis: The Need for Clear Answers Through Proper Questions 78
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution 72
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial 56
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 54
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population 50
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population 43
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab 43
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer 40
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial 28
The role of the molecular tumor board: learnings from the ROME trial 26
Totale 3.728
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 0 0 44 0 4 2 19 15 28
2022/2023348 30 62 27 10 35 30 1 30 84 1 32 6
2023/2024150 9 14 22 4 20 20 15 0 6 3 17 20
2024/2025935 5 52 32 51 86 143 43 46 89 97 117 174
2025/20261.531 112 133 114 178 158 119 245 113 79 179 68 33
2026/2027652 92 469 91 0 0 0 0 0 0 0 0 0
Totale 3.728